Evidence map›Paper›PMID 34815596›Full record

ArticleThe Ulster medical journal2021

Discovery of inhibition of

Rachael McIlroy, David W Nelson, B Cherie Millar, Alan Murphy, Juluri R Rao, Damian G Downey, John E Moore

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in The Ulster medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rachael McIlroyWellcome-Wolfson Institute For Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
David W NelsonPlant Pathology, AgriFood & Biosciences Institute, Newforge Lane, Belfast, BT9 5PX, Northern Ireland, UK.
B Cherie MillarWellcome-Wolfson Institute For Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
Alan MurphyNorthern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast BT9 7AD.
Juluri R RaoPlant Pathology, AgriFood & Biosciences Institute, Newforge Lane, Belfast, BT9 5PX, Northern Ireland, UK.
Damian G DowneyWellcome-Wolfson Institute For Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
John E MooreWellcome-Wolfson Institute For Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
Belfast City Hospital · GBUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) has now emerged as a major global public health problem. Certain bacterial pathogens, particularly Gram negative organisms associated with patients with cystic fibrosis (CF), have become resistant to several classes of antibiotics resulting in pan-resistance, which creates a clinical treatment dilemma. This study wished to explore the production of antibacterial extracellular metabolites from plant pathogenic fungi. Fungal Culture Extracts (FCEs) were prepared from 10 fungi (

Indexed as

BasidiomycotaBurkholderia cenocepaciaStenotrophomonas maltophiliaAgaricalesAnti-Bacterial AgentsArmillariaAscomycotaFungiFusariumHumansHypocrealesPolyporalesPseudomonas aeruginosaAnti-Bacterial Agents

Identifiers

PMID34815596
PMCPMC8581687
OpenAlexW3214629534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.